L. Silvia Munoz-Price

Enterprise Epidemiologist/Professor of Medicine

Medical College of Wisconsin

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

L. Silvia Munoz-Price is an Enterprise Epidemiologist and Professor of Medicine at the Medical College of Wisconsin, United States. Her research interests include infectious diseases, particularly focusing on SARS-CoV-2 and antimicrobial resistance. Recent publications highlight her work on infection prevention measures in healthcare facilities, as well as the epidemiology and outcomes of infections associated with resistant organisms.

Articles (9)

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Collaborators (2)

Rebekah Moehring

Associate Professor

Duke University

UNITED STATES

View details

Ibukunoluwa Kalu

Associate Professor

Duke University School of Medicine

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

L. Silvia Munoz-Price

Research Interests

Explore related searches

Contact this professor

About

Articles (9)

Asymptomatic screening for severe acute respiratory coronavirus virus 2 (SARS-CoV-2) as an infection prevention measure in healthcare facilities: Challenges and considerations

Predicting asymptomatic severe acute respiratory coronavirus virus 2 (SARS-CoV-2) infection rates of inpatients: A time-series analysis — CORRIGENDUM

Colistin Monotherapy versus Combination Therapy for Carbapenem-Resistant Organisms

Coronavirus disease 2019 (COVID-19) in long-term care facilities: A review of epidemiology, clinical presentations, and containment interventions

Surveillance cultures following a regional outbreak of carbapenem-resistant Acinetobacter baumannii

Incidence rate of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) among nurses in coronavirus disease 2019 (COVID-19) units versus non–COVID-19-units at a large academic medical center

Outcomes in patients with inflammatory bowel disease and acute gastrointestinal symptoms who test indeterminate for Clostridioides difficile

Predicting asymptomatic SARS-CoV-2 infection rates of inpatients: a time series analysis

Risk factors for the development of infections associated with carbapenemase-producing Enterobacteriaceae among previously colonized patients: A retrospective cohort study

Collaborators (2)

Rebekah Moehring

Ibukunoluwa Kalu

Make your next move.